Chartrand S - Search Results

1

Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials.

Citera G, Mysler E, Madariaga H, Cardiel MH, Castañeda O, Fischer A, Richette P, Chartrand S, Park JK, Strengholt S, Rivas JL, Thorat AV, Girard T, Kwok K, Wang L, Ponce de Leon D. Citera G, et al. Among authors: chartrand s. J Clin Rheumatol. 2021 Dec 1;27(8):e482-e490. doi: 10.1097/RHU.0000000000001552. J Clin Rheumatol. 2021. PMID: 32826657 Free PMC article.

2

Management of connective tissue disease-associated interstitial lung disease.

Chartrand S, Fischer A. Chartrand S, et al. Rheum Dis Clin North Am. 2015 May;41(2):279-94. doi: 10.1016/j.rdc.2015.01.002. Epub 2015 Feb 3. Rheum Dis Clin North Am. 2015. PMID: 25836643 Review.

3

Current approach to connective tissue disease-associated interstitial lung disease.

Solomon JJ, Chartrand S, Fischer A. Solomon JJ, et al. Among authors: chartrand s. Curr Opin Pulm Med. 2014 Sep;20(5):449-56. doi: 10.1097/MCP.0000000000000081. Curr Opin Pulm Med. 2014. PMID: 25022317 Review.

4

Assessment and management of connective tissue disease-associated interstitial lung disease.

Fischer A, Chartrand S. Fischer A, et al. Among authors: chartrand s. Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jun 22;32(1):2-21. Sarcoidosis Vasc Diffuse Lung Dis. 2015. PMID: 26237351 Review.

5

Rituximab for the treatment of connective tissue disease-associated interstitial lung disease.

Chartrand S, Swigris JJ, Peykova L, Fischer A. Chartrand S, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2016 Jan 15;32(4):296-304. Sarcoidosis Vasc Diffuse Lung Dis. 2016. PMID: 26847096

6

Longitudinal assessment of interstitial pneumonia with autoimmune features is encouraged.

Chartrand S, Lee JS, Fischer A. Chartrand S, et al. Respir Med. 2017 Nov;132:267. doi: 10.1016/j.rmed.2017.07.015. Epub 2017 Jul 21. Respir Med. 2017. PMID: 28760577 Free article. No abstract available.

7

Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.

Chartrand S, Lee JS, Swigris JJ, Stanchev L, Fischer A. Chartrand S, et al. Lung. 2019 Dec;197(6):709-713. doi: 10.1007/s00408-019-00276-7. Epub 2019 Oct 3. Lung. 2019. PMID: 31583453

8

A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.

Chartrand S, Swigris JJ, Peykova L, Chung J, Fischer A. Chartrand S, et al. J Rheumatol. 2016 May;43(5):887-92. doi: 10.3899/jrheum.150966. Epub 2016 Mar 1. J Rheumatol. 2016. PMID: 26932342

9

Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience.

Chartrand S, Swigris JJ, Stanchev L, Lee JS, Brown KK, Fischer A. Chartrand S, et al. Respir Med. 2016 Oct;119:150-154. doi: 10.1016/j.rmed.2016.09.002. Epub 2016 Sep 3. Respir Med. 2016. PMID: 27692137 Free article.

10

Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review.

Hoa S, Troyanov Y, Fritzler MJ, Targoff IN, Chartrand S, Mansour AM, Rich E, Boudabbouz H, Bourré-Tessier J, Albert M, Goulet JR, Landry M, Senécal JL. Hoa S, et al. Among authors: chartrand s. Scand J Rheumatol. 2018 May;47(3):210-224. doi: 10.1080/03009742.2017.1334814. Epub 2017 Oct 25. Scand J Rheumatol. 2018. PMID: 29065773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page